These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 17548565

  • 1. Pathogenesis of axonal and neuronal damage in multiple sclerosis.
    Dutta R, Trapp BD.
    Neurology; 2007 May 29; 68(22 Suppl 3):S22-31; discussion S43-54. PubMed ID: 17548565
    [Abstract] [Full Text] [Related]

  • 2. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 May 29; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 3. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE, Nichols PP, Bates D, Turnbull DM.
    Med Hypotheses; 2005 May 29; 64(4):669-77. PubMed ID: 15694681
    [Abstract] [Full Text] [Related]

  • 4. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G, Trapp B, Dutta R.
    Handb Clin Neurol; 2014 May 29; 122():101-13. PubMed ID: 24507515
    [Abstract] [Full Text] [Related]

  • 5. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep 29; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 6. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC, Hughes P, Perry VH.
    Rev Neurol; 2010 Sep 29; 30(12):1203-8. PubMed ID: 10935251
    [Abstract] [Full Text] [Related]

  • 7. Inflammation and degeneration in multiple sclerosis.
    Brück W, Stadelmann C.
    Neurol Sci; 2003 Dec 29; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [Abstract] [Full Text] [Related]

  • 8. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L.
    N Engl J Med; 1998 Jan 29; 338(5):278-85. PubMed ID: 9445407
    [Abstract] [Full Text] [Related]

  • 9. [Axonal damage in multiple sclerosis].
    Bartosik-Psujek H, Stelmasiak Z.
    Neurol Neurochir Pol; 2002 Jan 29; 36(3):505-12. PubMed ID: 12185807
    [Abstract] [Full Text] [Related]

  • 10. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord.
    DeBoy CA, Zhang J, Dike S, Shats I, Jones M, Reich DS, Mori S, Nguyen T, Rothstein B, Miller RH, Griffin JT, Kerr DA, Calabresi PA.
    Brain; 2007 Aug 29; 130(Pt 8):2199-210. PubMed ID: 17557778
    [Abstract] [Full Text] [Related]

  • 11. Protecting axons in multiple sclerosis.
    Wilkins A, Scolding N.
    Mult Scler; 2008 Sep 29; 14(8):1013-25. PubMed ID: 18632772
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A, Toledo EG, Alexander JS, Kelley RE.
    J Neuroimaging; 2004 Jul 29; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA.
    Neurology; 2007 May 29; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [Abstract] [Full Text] [Related]

  • 14. Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
    Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F.
    Trends Neurosci; 2010 Apr 29; 33(4):202-10. PubMed ID: 20153532
    [Abstract] [Full Text] [Related]

  • 15. Remyelination protects axons from demyelination-associated axon degeneration.
    Irvine KA, Blakemore WF.
    Brain; 2008 Jun 29; 131(Pt 6):1464-77. PubMed ID: 18490361
    [Abstract] [Full Text] [Related]

  • 16. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A.
    Clin Neurol Neurosurg; 2004 Jun 29; 106(3):246-8. PubMed ID: 15177777
    [Abstract] [Full Text] [Related]

  • 17. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG.
    Nat Rev Neurosci; 2006 Dec 29; 7(12):932-41. PubMed ID: 17115075
    [Abstract] [Full Text] [Related]

  • 18. The pathology of multiple sclerosis and its evolution.
    Lassmann H.
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct 29; 354(1390):1635-40. PubMed ID: 10603616
    [Abstract] [Full Text] [Related]

  • 19. Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.
    De Keyser J, Zeinstra E, Mostert J, Wilczak N.
    Trends Pharmacol Sci; 2004 Feb 29; 25(2):67-71. PubMed ID: 15102491
    [Abstract] [Full Text] [Related]

  • 20. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.